Taro shareholders approve merger with Sun Pharma EP News Bureau May 24, 2024 Upon the completion of merger Taro will become a privately held company wholly owned by Sun Pharma
Sun Pharma arm to acquire Aquinox Pharmaceuticals (Canada) EP News Bureau Jul 29, 2020 The cost of acquisition is about $8.2 million